Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Schimel’s Diamondback Capital Will Not Face Criminal Charges

Diamondback Capital Management, one of the largest hedge funds ensnared by the government’s insider trading crackdown, will not face criminal charges” reports the New York Times. Instead, it “will pay more than $9 million in fines and penalties to resolve its role in the investigation.”

Diamondback was able to enter into a non prosecution agreement with the US Attorney’s office. “The government agreed not to bring criminal charges against Diamondback, citing the fund’s prompt cooperation and voluntary adoption of remedial measures.” Under the terms of its agreement with the SEC and the federal government, Diamondback “will forfeit $6 million in ill-gotten gains and pay a civil penalty of $3 million.” George Canellos, head of the SEC’s New York Office, said of the pact: “We believe that the proposed settlement appropriately sanctions the misconduct while giving due credit to Diamondback for its substantial assistance in the government’s investigation and the pending actions against former employees and their co-defendants.”

Diamondback’s pact does not include any admission that the fund “neither admits nor denies” wrongdoing. This is a departure from the SEC’s historical practices. “This month, the S.E.C. announced that it would no longer permit defendants to ‘neither admit nor deny’ charges if the defendant admitted to or had been convicted of criminal violations,” reports the New York Times. “The new policy also applies to cases like the Diamondback one in which a company enters a nonprosecution agreement with criminal authorities.”

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!